Genetic Testing Market Research Report for the period of 2018-2024 that shows the growth of the market is rising at a Steady CAGR to 2024. Increasing prevalence of cancer and other genetic diseases worldwide will drive industry growth over the forecast timeframe. Breast cancer is the second leading cause of cancer deaths among women. According to the Pan American Health Organization (PAHO), around 4,08,200 breast cancer cases and 92,000 cancer deaths were recorded in 2013. The number of breast cancer cases in Americas is expected to grow by 46% by 2030. Furthermore, increasing awareness among patients pertaining to early detection of diseases helps patients to undergo timely treatment and minimize the risks associated with the diseases. Aforementioned factors are expected to fuel the demand for genetic testing thereby propelling the market growth. Genetic Testing Market will reach USD 22.5 billion by 2024; as per a new research report. Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1130965/ Availability of new tests owing to technological advancements in the field of genetic testing will serve to be high impact rendering factor. Demand for genetic testing is increasing due to the development of non-invasive tests that can be used in detection of genetic abnormalities during early pregnancy. Availability of highly sensitive and efficient tests for early diagnosis of diseases will boost the market growth. Moreover, increasing consumer demand for personalized medicines based on molecular basis of the diseases will further drive the genetic testing market during the forthcoming years. U.S. genetic testing market dominated the industry owing to increasing prevalence of chronic diseases, developed healthcare facilities and technological advancements. Rising prevalence of genetic diseases such as cancer, cardiac disease, neurofibromatosis, cystic fibrosis, Turner syndrome and spinal muscular atrophy will augment the market growth. Moreover, increasing insurance coverage and regulatory support for direct to consumer (DTC) genetic testing coupled with reduction in the cost of genetic tests is expected to propel the demand for genetic testing in the U.S. over the forecast period. Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1130965/ Diagnostic testing dominated the genetic testing market and accounted for USD 5,690.6 million in 2017. It is expected to witness robust growth during the forecast period attributable to the increasing prevalence of chronic diseases worldwide. Diagnostic testing enables early diagnosis of diseases allowing patients to undergo timely therapeutic treatment, lower the severity of diseases and reduce the mortality rate. Cardiovascular disease diagnosis segment is expected to grow at the fastest rate during the forthcoming years. Cardiac diseases are the leading cause of deaths worldwide and are caused by a combination of genetic and environmental factors. The onset and treatment of CVDs can be controlled if it is diagnosed prior to manifestation of actual disease in patients with high risk of developing a CVD. Genetic testing helps to reliably determine an individual?s risk to develop CVDs based on their genetic data using preventive genetic screening. Some of the notable industry players operating in global genetic testing market are 23andMe, Abbott Molecular, Bayer Diagnostics, Biocartis, BioHelix, BioMerieux, BGI, Celera Genomics, Cepheid, Counsyl, deCODEme, Genentech, Genomictree, Genomic Health, HTG Molecular Diagnostics, IntegraGen, LabCorp Diagnostics, Luminex, MolecularMD, Myriad, Natera, PacBio, Pathway Genomics, Qiagen, Roche Diagnostics, Sequenom and Siemens. Table of Content: Chapter 1. Genetic Testing Market Methodology and Scope Chapter 2. Genetic Testing Market Executive Summary Chapter 3. Genetic Testing Industry Insights Chapter 4. Genetic Testing Market, By Test Type Chapter 5. Genetic Testing Market, By Application Chapter 6. Genetic Testing Market, By Region Chapter 7. Genetic Testing Market Company Profiles More Report At: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html Related Report: Global Newborn Genetic Testing Market Research Report Forecast 2017-2022 The Global Newborn Genetic Testing Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Newborn Genetic Testing industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Newborn Genetic Testing market study provides comprehensive data which enhances the understanding, scope and application of this report. https://www.marketstudyreport.com/reports/global-newborn-genetic-testing-market-research-report-forecast-2017-2022?utm_source=RR-SP About Us: Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management. Contact Us: Market Study Report 4 North Main Street, Selbyville, Delaware 19975 USA Phone:1-302-273-0910 US Toll Free:1-866-764-2150 Email:[email protected] Website:https://www.marketstudyreport.com Blog: https://www.marketstudyreport.com/blog/